tiprankstipranks
Trending News
More News >
Q32 Bio presents results from SIGNAL-AA Part 2a trial of bempikibart
PremiumThe FlyQ32 Bio presents results from SIGNAL-AA Part 2a trial of bempikibart
2M ago
Cautious Optimism: Q32 Bio’s Strategic Shift to Focus on Bempikibart for Alopecia Areata
Premium
Ratings
Cautious Optimism: Q32 Bio’s Strategic Shift to Focus on Bempikibart for Alopecia Areata
3M ago
IBM initiated, Southwest upgraded: Wall Street’s top analyst calls
Premium
The Fly
IBM initiated, Southwest upgraded: Wall Street’s top analyst calls
3M ago
Q32 Bio Advances Clinical Trials for Growth Opportunities
PremiumCompany AnnouncementsQ32 Bio Advances Clinical Trials for Growth Opportunities
4M ago
Q32 Bio price target lowered to $22 from $64 at BMO Capital
Premium
The Fly
Q32 Bio price target lowered to $22 from $64 at BMO Capital
5M ago
Q32 Bio downgraded to Neutral at Guggenheim after failure in atopic dermatitis
Premium
The Fly
Q32 Bio downgraded to Neutral at Guggenheim after failure in atopic dermatitis
5M ago
Q32 Bio downgraded to Market Perform from Outperform at Leerink
PremiumThe FlyQ32 Bio downgraded to Market Perform from Outperform at Leerink
5M ago
Q32 Bio downgraded to Outperform from Strong Buy at Raymond James
Premium
The Fly
Q32 Bio downgraded to Outperform from Strong Buy at Raymond James
5M ago
Q32 Bio downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
Q32 Bio downgraded to Equal Weight from Overweight at Wells Fargo
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100